DJIA 17,111.73 40.51 0.24%
NASDAQ 4,511.06 5.21 0.12%
S&P 500 1,984.01 6.21 0.31%
market minute promo

Johnson & Johnson (NYSE: JNJ)

107.05 0.51 (0.48%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JNJ $107.05 0.48%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.50
Previous Close $106.54
Daily Range $106.45 - $107.17
52-Week Range $85.50 - $108.77
Market Cap $301.9B
P/E Ratio 19.69
Dividend (Yield) $2.80 (2.6%)
Ex-Dividend Date
Dividend Pay Date
08/22/14
09/09/14
Volume 1,200,629
Average Daily Volume 5,826,613
Current FY EPS $5.92

Sector

Healthcare

Industry

Drugs

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website: http://www.jnj.com/

News & Commentary Rss Feed

Gilead Sciences, Inc. Stock's Stunning New Opportunity

The biotech giant has spent over $1.2 billion to buy blood cancer drugs. And with Zydelig's recent approval, it looks like it's finally struck gold.

Cintas Beats on Q1 Earnings with Robust Margin Expansion - Analyst Blog

UPDATE 1-Johnson & Johnson to buy private drug developer for $1.75 bln

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

How Will Johnson & Johnson (JNJ) Stock Be Affected by This Acquisition?

J&J to buy Alios BioPharma for $1.75 billion

Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 01, 2014

Johnson & Johnson to buy private drug developer for $1.75 bln

Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog

Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog

Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog

Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog

See More JNJ News...

JNJ's Top Competitors

JNJ $107.05 (0.48%)
Current stock: JNJ
PFE $29.92 (0.49%)
Current stock: PFE
MRK $59.80 (0.66%)
Current stock: MRK
BSX $11.90 (-0.17%)
Current stock: BSX